Cardiff Oncology (CRDF) Receivables - Other (2022 - 2025)
Cardiff Oncology's Receivables - Other history spans 4 years, with the latest figure at $300000.0 for Q4 2025.
- For Q4 2025, Receivables - Other fell 25.0% year-over-year to $300000.0; the TTM value through Dec 2025 reached $300000.0, down 25.0%, while the annual FY2025 figure was $300000.0, 25.0% down from the prior year.
- Receivables - Other for Q4 2025 was $300000.0 at Cardiff Oncology, down from $400000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $600000.0 in Q4 2023 and bottomed at $300000.0 in Q4 2025.
- The 4-year median for Receivables - Other is $450000.0 (2022), against an average of $450000.0.
- The largest annual shift saw Receivables - Other rose 20.0% in 2023 before it tumbled 33.33% in 2024.
- A 4-year view of Receivables - Other shows it stood at $500000.0 in 2022, then increased by 20.0% to $600000.0 in 2023, then tumbled by 33.33% to $400000.0 in 2024, then fell by 25.0% to $300000.0 in 2025.
- Per Business Quant, the three most recent readings for CRDF's Receivables - Other are $300000.0 (Q4 2025), $400000.0 (Q4 2024), and $600000.0 (Q4 2023).